Search

Displaying results 2011 - 2020 of 10000 in total
  1. Drug

    Phleum pratense pollen

    go.drugbank.com/drugs/DB10394
    ApprovedInvestigational

    Phleum pratense pollen allergenic extract is used in allergenic testing.

    Mixtures: SLITone ULTRA D. glomerata/ L. perenne/ P. pratense/ P. pratensis/ A. odoratum, ORALAIR 100 IR + 300 IR SublingualtablettenProducts: Standardized Grass Pollen - Timothy (100 Bau/ml), GRAZAX 75.000 SQ-T ORAL LIYOFILIZAT 100 TABLET
  2. Drug

    Cevimeline

    go.drugbank.com/drugs/DB00185
    Approved

    Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3.

  3. Drug

    Otilonium

    go.drugbank.com/drugs/DB13500
    Investigational

    Mixtures: BROMURO DE OTILONIO + SIMETICONA 40MG + 200MG, DOLOSPAS 40 MG/80 MG FİLM KAPLI TABLET, 90 ADETProducts: EKSPAZ 40 MG FILM TABLET, 60 ADET, BROPASMOL(R)40 MG TABLETAS
  4. Drug

    Amivantamab

    go.drugbank.com/drugs/DB16695
    ApprovedInvestigational

    [A235103,A235123] Patients with NSCLC with exon 20 insertion mutations in EGFR do not respond to tyrosine kinase inhibitors, and were generally treated with platinum-based therapy. … non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based

  5. Drug

    Besifloxacin

    go.drugbank.com/drugs/DB06771
    Approved

    FDA approved on May 28, 2009.

    Products: BESIVANCE % 0,6 OFTALMIK SÜSPANSIYON, 5 ML
  6. Drug

    Meldonium

    go.drugbank.com/drugs/DB13723
    Investigational

    Products: SATURID 100 MG/ ML I.V. ENJEKSIYONLUK ÇÖZELTI IÇEREN AMPUL
  7. Drug

    Cerebrolysin

    go.drugbank.com/drugs/DB16599
    Investigational

    Products: Ambotonin 215,2 mg/ml - parenterale Lösung Injektionslösung/Konzentrat zur Herstellung einer Infusionslösung
  8. Drug

    Pirenoxine

    go.drugbank.com/drugs/DB15945
    Investigational

    Products: KARY UNI OPHTHALMIC SUSPENSION 0.05 mg/ml
  9. Target

    Glial cell line-derived neurotrophic factor

    go.drugbank.com/bio_entities/BE0002486
    TargetHumans

    Neurotrophic factor that enhances survival and morphological differentiation of dopaminergic neurons and increases their high-affinity dopamine uptake (PubMed:8493557). Acts by binding to its coreceptor, GFRA1, leading to autophosphoryla...

    Polypeptides: Glial cell line-derived neurotrophic factor
  10. Drug

    Tocofersolan

    go.drugbank.com/drugs/DB11635
    Approved

    It was approved by the European Medicines Agency (EMA) in June 2009 under the market name Vedrop. … D-Alpha-tocopheryl polyethylene glycol 1000 succinate (Tocofersolan, Vedrop), has been developed in Europe as an orally bioavailable source of vitamin E in children suffering from cholestasis [L2371].

    Categories: Vitamin E, Compounds used in a research, industrial, or household settingSynonyms: D-.ALPHA.-TOCOPHEROL POLYETHYLENE GLYCOL 1000 SUCCINATE, VITAMIN E POLYETHYLENE GLYCOL SUCCINATE